{
    "2019-05-27": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Dow on Longest Losing Streak in 8 Yrs: 5 Stocks Still Up in ETF",
                "features": {
                    "keywords": [
                        "Dow",
                        "Longest Losing Streak",
                        "ETF"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-20",
                "original_text": "Pfizer's (PFE) Epilepsy Drug Lyrica Fails in Phase III Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Lyrica",
                        "Phase III Study",
                        "fails"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-04-10",
                "original_text": "3 Peninsula biotech IPOs show off diversity of targets, seek to raise more than $400 million",
                "features": {
                    "keywords": [
                        "biotech IPOs",
                        "diversity of targets",
                        "$400 million"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}